These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31308681)

  • 21. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis.
    Vadakayil AR; Dandekeri S; Kambil SM; Ali NM
    Indian Dermatol Online J; 2015; 6(5):322-5. PubMed ID: 26500861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis.
    Park YJ; Yoo SA; Hwang D; Cho CS; Kim WU
    Exp Mol Med; 2016 Feb; 48(2):e211. PubMed ID: 26915672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
    Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
    Coates LC; FitzGerald O; Helliwell PS; Paul C
    Semin Arthritis Rheum; 2016 Dec; 46(3):291-304. PubMed ID: 27388027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malondialdehyde, lipoprotein-a, lipoprotein ratios, comprehensive lipid tetrad index and atherogenic index as surrogate markers for cardiovascular disease in patients with psoriasis: a case-control study.
    Wadhwa D; Mahajan VK; Mehta KS; Chauhan PS; Yadav RS; Bhushan S; Sharma V; Sharma A; Sharma A; Chauhan S
    Arch Dermatol Res; 2019 May; 311(4):287-297. PubMed ID: 30830310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies.
    Kaiser H; Näslund-Koch C; Kvist-Hansen A; Skov L
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):303-321. PubMed ID: 38291285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement.
    Damiani G; Pacifico A; Rizzi M; Santus P; Bridgewood C; Bragazzi NL; Adawi M; Watad A
    Clin Rheumatol; 2020 Oct; 39(10):2981-2988. PubMed ID: 32240433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
    Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
    J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Immune-Inflammation Index (SII) Predicts Increased Severity in Psoriasis and Psoriatic Arthritis.
    Yorulmaz A; Hayran Y; Akpinar U; Yalcin B
    Curr Health Sci J; 2020; 46(4):352-357. PubMed ID: 33717509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psoriasis and oxidative stress].
    Péter I; Jagicza A; Ajtay Z; Kiss I; Németh B
    Orv Hetil; 2016 Nov; 157(45):1781-1785. PubMed ID: 27817235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Serum Adenosine Deaminase and Inflammatory Markers in Psoriatic Patients.
    Moustafa YM; Elsaied MA; Abd-Elaaty EM; Elsayed RA
    Indian J Dermatol; 2019; 64(3):207-212. PubMed ID: 31148859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study.
    Chiu HY; Chang WL; Huang WF; Wen YW; Tsai YW; Tsai TF
    J Am Acad Dermatol; 2015 Sep; 73(3):429-38. PubMed ID: 26188627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone.
    Eder L; Jayakar J; Shanmugarajah S; Thavaneswaran A; Pereira D; Chandran V; Rosen CF; Gladman DD
    Ann Rheum Dis; 2013 May; 72(5):715-20. PubMed ID: 22736087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-angiogenic properties of orosomucoid (ORM).
    Irmak S; Oliveira-Ferrer L; Singer BB; Ergün S; Tilki D
    Exp Cell Res; 2009 Nov; 315(18):3201-9. PubMed ID: 19651122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
    Montaudié H; Albert-Sabonnadière C; Acquacalda E; Fontas E; Danré A; Roux C; Ortonne JP; Lacour JP; Euller-Ziegler L; Passeron T
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1186-91. PubMed ID: 23981008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orosomucoid: a promising biomarker for the assessment of exercise-induced fatigue triggered by basic combat training.
    Ruan Y; Xiang KF; Zhang HM; Qin Z; Sun Y; Wan JJ; Gu W; Liu X
    BMC Sports Sci Med Rehabil; 2022 Jun; 14(1):100. PubMed ID: 35658935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythromycin has therapeutic efficacy on muscle fatigue acting specifically on orosomucoid to increase muscle bioenergetics and physiological parameters of endurance.
    Wan J; Qin Z; Lei H; Wang P; Zhang Y; Feng J; Wei J; Sun Y; Liu X
    Pharmacol Res; 2020 Nov; 161():105118. PubMed ID: 32777256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriatic Arthritis Is an Indicator of Significant Renal Damage in Patients with Psoriasis: An Observational and Epidemiological Study.
    Khan A; Haider I; Ayub M; Humayun M
    Int J Inflam; 2017; 2017():5217687. PubMed ID: 28421157
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis.
    Eder L; Dey A; Joshi AA; Boehncke WH; Mehta NN; Szentpetery A
    J Rheumatol Suppl; 2019 Jun; 95():20-27. PubMed ID: 31154400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.